Free Trial

Vir Biotechnology (VIR) SEC Filings & 10K Form

$11.23
-0.75 (-6.26%)
(As of 06/7/2024 ET)

Recent Vir Biotechnology SEC Filings

DateFilerForm TypeView
06/07/2024
4:01 PM
PEREZ ROBERT J (Reporting)
Vir Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/05/2024
5:04 AM
Vir Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/03/2024
11:15 AM
Ramasastry Saira (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
11:16 AM
SATO VICKI L (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
11:17 AM
SCANGOS GEORGE A (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
11:18 AM
Sigal Charles Elliott (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
10:57 AM
Eisner Mark (Reporting)
Vir Biotechnology (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/03/2024
10:59 AM
Hatfield Jeffrey S. (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
11:08 AM
MORE ROBERT J (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
11:13 AM
Napolitano Janet (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
11:14 AM
NELSEN ROBERT (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
1:38 PM
BISCHOFBERGER NORBERT W (Reporting)
Vir Biotechnology (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/31/2024
1:40 PM
BISCHOFBERGER NORBERT W (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
1:42 PM
Farid Ramy (Reporting)
Vir Biotechnology (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/31/2024
1:43 PM
Farid Ramy (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
3:06 PM
Vir Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2024
3:05 PM
Vir Biotechnology (Filer)
Form DEFA14A
04/19/2024
7:40 AM
Vir Biotechnology (Filer)
Form ARS
04/19/2024
7:32 AM
Vir Biotechnology (Filer)
Form DEF 14A
04/19/2024
7:35 AM
Vir Biotechnology (Filer)
Form DEFA14A
04/18/2024
7:44 AM
Vir Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/04/2024
3:14 PM
De Backer Marianne (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
7:58 PM
HANLY ANN M. (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2024
11:18 AM
Lee Sung (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2024
6:32 PM
Lee Sung (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2024
6:32 PM
De Backer Marianne (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2024
6:34 PM
HANLY ANN M. (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2024
6:30 PM
SCANGOS GEORGE A (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2024
6:31 PM
Pang Phillip (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2024
3:32 PM
SCANGOS GEORGE A (Reporting)
Vir Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/20/2024
8:02 PM
SCANGOS GEORGE A (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2024
3:35 PM
SCANGOS GEORGE A (Reporting)
Vir Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/16/2024
5:56 PM
Pang Phillip (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2024
6:59 AM
STATE STREET CORP (Filed by)
Vir Biotechnology (Subject)
Form SC 13G
01/23/2024
3:14 PM
BlackRock Inc. (Filed by)
Vir Biotechnology (Subject)
Form SC 13G/A
01/03/2024
1:47 PM
Pang Phillip (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/03/2023
3:33 PM
Vir Biotechnology (Filer)
Form S-3ASR
11/03/2023
3:37 PM
Vir Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/20/2023
1:15 PM
MORE ROBERT J (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/18/2023
1:14 PM
SCANGOS GEORGE A (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2023
7:01 AM
Vir Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Bill Clinton Backing Biden Replacement??? (Ad)

Do you want to see who I believe will be the next president of the U.S.A? It won’t be Biden…And it won’t be Trump.

Click here to see why it will be ______ _________.
09/20/2023
5:02 AM
Vir Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/18/2023
2:54 PM
SCANGOS GEORGE A (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/03/2023
3:14 PM
Vir Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/20/2023
7:04 AM
Vir Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/05/2023
8:00 PM
SVF Endurance Ltd (0001782338) (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2023
3:15 PM
SATO VICKI L (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/30/2023
8:00 PM
SVF Endurance Ltd (0001782338) (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/30/2023
4:17 PM
SATO VICKI L (Reporting)
Vir Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/29/2023
4:01 PM
SVF Endurance Ltd (0001782338) (Reporting)
Vir Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/22/2023
8:00 PM
SVF Endurance Ltd (0001782338) (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2023
8:00 PM
SVF Endurance Ltd (0001782338) (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2023
8:00 PM
SVF Endurance Ltd (0001782338) (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2023
3:30 PM
Pang Phillip (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:VIR) was last updated on 6/8/2024 by MarketBeat.com Staff

From Our Partners